Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 7, 2013, Pages 923-928

  Barton, R C ^a   Hobson, R P ^a   McLoughlin, H ^a   Morris, A ^a   Datta, B ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; PREDNISOLONE; VORICONAZOLE;

AGED; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FUNGAL COLONIZATION; HUMAN; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM CULTURE; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; PULMONARY ASPERGILLOSIS; RESPIRATORY SYSTEM; SPUTUM; YOUNG ADULT;

EID: 84879156154     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1827-7     Document Type: Article

References (25)

1. Meersseman W, Van WE (2007) Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med 33:1679-1681
2. Ader F (2010) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. Curr Infect Dis Rep 12:409-416
3. Bulpa P, Dive A, Sibille Y (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30:782-800
4. Bouza E, Guinea J, Pelaez T et al (2005) Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol 43:2075-2079
5. de Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821
6. Felton TW, Baxter C, Moore CB et al (2010) Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 51:1383-1391
7. Campbell C, Johnson EM, Philpot C, Warnock DW (1996) Identification of pathogenic fungi. Public Health Laboratory Service, London
8. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2013. http://www.goldcopd.org/uploads/users/files/GOLD-Report-2011- Feb21.pdf. Accessed 3 January 2013
9. Denning DW, Riniotis K, Dobrashian R et al (2003) Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37(SUPPL 3):S265-S280
10. Greenberger PA (2002) Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110:685-692
11. Pashley CH, Fairs A, Morley JP et al (2012) Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol 50:433-438
12. Mortensen KL, Johansen HK, Fuursted K et al (2011) A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis 30(11):1355-1363
13. Lionakis MS, Kontoyiannis DP (2003) Glucocorticoids and invasive fungal infections. Lancet 362:1828-1838
14. Ng TT, Robson GD, Denning DW (1994) Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 140:2475-2479
15. O'Donnell MR, Schmidt GM, Tegtmeier BR et al (1994) Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12:827-834
16. Peter E, Bakri F, Ball DM et al (2002) Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy. Clin Infect Dis 35:e54-e56
17. Leav BA, Fanburg B, Hadley S (2000) Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med 343:586
18. Guinea J, Torres-Narbona M, Gijon P et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870-877
19. He H, Ding L, Li F et al (2011) Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study. Crit Care 15:R5
20. Bulpa PA, Dive AM, Garrino MG et al (2001) Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 27:59-67
21. Denning DW, Lee JY, Hostetler JS et al (1994) NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97:135-144
22. Gao X, Chen L, Hu G et al (2010) Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests. Ann Saudi Med 30:193-197
23. Min KH, Park SJ, Kim SR et al (2011) Coexistence of allergic bronchopulmonary aspergillosis and active pulmonary tuberculosis. Am J Respir Crit Care Med 183:137-139
24. Baxter CG, Bishop P, Low SE et al (2011) Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography. Thorax 66:638-640
25. Chrdle A, Mustakim S, Bright-Thomas RJ et al (2012) Aspergillus bronchitis without significant immunocompromise. Ann NY Acad Sci 1272:73-85